- Title: Subtitle
- Sea-BCMA Mono- and Combination Therapy in Patients with Relapsed/Refractory Multiple Myeloma: Updated Results of a Phase 1 Study (SGNBCMA-001)
- Creators
- James E. Hoffman - Sylvester Comprehensive Cancer CenterBrea Lipe - University of Rochester Medical CenterJason Melear - Texas OncologyMichaela Liedtke - Stanford UniversityMark A. Schroeder - Washington University in St. LouisRuben Niesvizky - Weill Cornell MedicineChristopher Strouse - University of IowaChristopher A. Yasenchak - Willamette Valley Cancer Institute and Research CenterDamian J. Green - Fred Hutch Cancer CenterJeremy Sauer - 10Seagen Inc., Bothell, WAYinghui Wang - 10Seagen Inc., Bothell, WAPhoenix Ho - 10Seagen Inc., Bothell, WAAl-Ola Abdallah - 11University of Kansas Medical Center, Kansas City, KS
- Resource Type
- Abstract
- Publication Details
- Blood, Vol.140(Supplement 1), pp.10160-10162
- DOI
- 10.1182/blood-2022-157347
- ISSN
- 0006-4971
- eISSN
- 1528-0020
- Language
- English
- Date published
- 11/15/2022
- Academic Unit
- Hematology, Oncology, and Blood & Marrow Transplantation; Internal Medicine
- Record Identifier
- 9984363267302771
Abstract
Sea-BCMA Mono- and Combination Therapy in Patients with Relapsed/Refractory Multiple Myeloma: Updated Results of a Phase 1 Study (SGNBCMA-001)
Blood, Vol.140(Supplement 1), pp.10160-10162
11/15/2022
DOI: 10.1182/blood-2022-157347
Details
Metrics
11 Record Views